Nivolumab With Ipilimumab in Subjects With Neuroendocrine Tumors
Clinical trial NCT03420521 · TERMINATED
Trial details
- NCT number
- NCT03420521
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-09
- Primary completion
- 2021-11-24
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.